Literature DB >> 12378124

Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder.

Harumi Jyonouchi1, Sining Sun, Nanae Itokazu.   

Abstract

OBJECTIVES: Children with autism spectrum disorder (ASD) frequently reveal various gastrointestinal (GI) symptoms that may resolve with an elimination diet along with apparent improvement of some of the behavioral symptoms. Evidence suggests that ASD may be accompanied by aberrant (inflammatory) innate immune responses. This may predispose ASD children to sensitization to common dietary proteins (DP), leading to GI inflammation and aggravation of some behavioral symptoms.
METHODS: We measured IFN-gamma, IL-5, and TNF-alpha production against representative DPs [gliadin, cow's milk protein (CMP), and soy] by peripheral blood mononuclear cells (PBMCs) from ASD and control children [those with DP intolerance (DPI), ASD siblings, and healthy unrelated children]. We evaluated the results in association with proinflammatory and counter-regulatory cytokine production with endotoxin (LPS), a microbial product of intestinal flora and a surrogate stimulant for innate immune responses.
RESULTS: ASD PBMCs produced elevated IFN-gamma and TNF-alpha, but not IL-5 with common DPs at high frequency as observed in DPI PBMCs. ASD PBMCs revealed increased proinflammatory cytokine responses with LPS at high frequency with positive correlation between proinflammatory cytokine production with LPS and IFN-gamma and TNF-alpha production against DPs. Such correlation was less evident in DPI PBMCs.
CONCLUSION: Immune reactivity to DPs may be associated with apparent DPI and GI inflammation in ASD children that may be partly associated with aberrant innate immune response against endotoxin, a product of the gut bacteria. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12378124     DOI: 10.1159/000065416

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  64 in total

1.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

2.  Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity.

Authors:  Gehan A Mostafa; Laila Y Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-04-25       Impact factor: 8.322

Review 3.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

4.  Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders.

Authors:  Paul Ashwood; Joseph Schauer; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2009-02-10       Impact factor: 3.478

Review 5.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

6.  Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Authors:  Amanda M Enstrom; Charity E Onore; Judy A Van de Water; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2009-08-08       Impact factor: 7.217

Review 7.  Evolution in the Understanding of Autism Spectrum Disorder: Historical Perspective.

Authors:  Mark Mintz
Journal:  Indian J Pediatr       Date:  2016-04-07       Impact factor: 1.967

8.  Family analysis of immunoglobulin classes and subclasses in children with autistic disorder.

Authors:  Mirko Spiroski; Vladimir Trajkovski; Dejan Trajkov; Aleksandar Petlichkovski; Olivija Efinska-Mladenovska; Slavica Hristomanova; Eli Djulejic; Meri Paneva; Jadranka Bozhikov
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

9.  Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism.

Authors:  S Jill James; Stepan Melnyk; George Fuchs; Tyra Reid; Stefanie Jernigan; Oleksandra Pavliv; Amanda Hubanks; David W Gaylor
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

Review 10.  Autistic enterocolitis: fact or fiction?

Authors:  Polymnia Galiatsatos; Adrian Gologan; Esther Lamoureux
Journal:  Can J Gastroenterol       Date:  2009-02       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.